title: [ED-71].
authors.affiliation: Chugai Pharmaceutical Co., Ltd.
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Takahashi
authors.forename: Naoki
authors.initials: N
authors.lastname: Tsuji
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Uchiyama
mesh_terms: D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000517:prevention & control; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D014807:Vitamin D / Q000031:analogs & derivatives
chemical_list: D014807:Vitamin D; D002117:Calcitriol; C547512:eldecalcitol; D002118:Calcium